Angiotensin 1-9 vs Vasostatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Angiotensin 1-9 (Ang 1-9) is a 9-amino acid peptide formed when ACE2 cleaves the C-terminal leucine from angiotensin I (Ang I, 10 AA). Discovered as part of the counter-regulatory renin-angiotensin system (RAS), Ang 1-9 opposes the hypertensive and tissue-damaging actions of angi...
Calculate Angiotensin 1-9 dose →Vasostatin refers to the N-terminal fragments of chromogranin A (CgA), particularly CgA1-76 (Vasostatin-1) and CgA1-113 (Vasostatin-2), generated by proteolytic processing of the chromogranin A precursor. While catestatin (CgA352-372) is the C-terminal CgA fragment with anti-cate...
Calculate Vasostatin dose →| Parameter | Angiotensin 1-9 | Vasostatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical Research | Preclinical Research |
| Half-Life | ~20-30 minutes | ~20-30 minutes (estimated) |
| Typical Dose | 40-400 ng/kg/min IV infusion (animal) | 0.1-10 nmol/kg IV (animal) |
| Frequency | Acute infusion protocols | Acute dosing |
| Route | IV/SC (research) | IV (research) |
| FDA Status | Research compound | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.